Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption

• Egile Nagusiak: Chen-he Zhou (Egilea), Jia-hong Meng (Egilea), Yu-te Yang (Egilea), Bin Hu (Egilea), Jian-qiao Hong (Egilea), Zheng-tao Lv (Egilea), Kun Chen (Egilea), Boon Chin Heng (Egilea), Guang-yao Jiang (Egilea), Jian Zhu (Egilea), Zhao-hui Cheng (Egilea), Wei Zhang (Egilea), Le Cao (Egilea), Wei Wang (Egilea), Wei-liang Shen (Egilea), Shi-gui Yan (Egilea), Hao-bo Wu (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2018-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Osteoporosis is a common health problem worldwide caused by an imbalance of bone formation vs. bone resorption. However, current therapeutic approaches aimed at enhancing bone formation or suppressing bone resorption still have some limitations. In this study, we demonstrated for the first time that...